How a pill approved 25 years ago transformed cancer treatment

Dr. Brian Druker, director of the Knight Cancer Institute at Oregon Health & Science University, championed the drug that became Gleevec. Kristyna Wentz-Graff/Oregon Health & Science University hide caption toggle caption Kristyna Wentz-Graff/Oregon Health & Science University Get the latest on the science of healthy living in the NPR Health newsletter , sent weekly. When Mel Mann was diagnosed with cancer at 37 years old, he was told he'd have three years to live. It was January 1995. …